Cargando…

Digital health information on surgical treatment options for overactive bladder is underrepresented

PURPOSE: Digital health information gains growing importance in the medical landscape. Despite its opportunities, there is a risk of patient misinformation which may adversely influence the patient–physician relationship. This investigation aimed to identify and compare differences in the content an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hüsch, Tanja, Ober, Sita, Haferkamp, Axel, Schneidewind, Laila, Saar, Matthias, Kranz, Jennifer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352412/ https://www.ncbi.nlm.nih.gov/pubmed/37272960 http://dx.doi.org/10.1007/s00345-023-04447-3

Ejemplares similares

Comparison of online health information between different digital platforms for pelvic organ prolapse
por: Hüsch, Tanja, et al.
Publicado: (2022)

Gender gap at a large European urological congress: still at the beginning
por: Hüsch, Tanja, et al.
Publicado: (2021)

Do or Don’t: Results of a Multinational Survey on Antibiotic Prophylaxis in Urodynamics
por: Stangl, Fabian P., et al.
Publicado: (2023)

Overactive bladder syndrome pharmacotherapy: future treatment options
por: Wróbel, Andrzej
Publicado: (2015)

The surgical management of the refractory overactive bladder
por: Vasdev, Nikhil, et al.
Publicado: (2010)

Utilization of surgical safety checklists by urological surgeons in Germany: a nationwide prospective survey
por: Borgmann, Hendrik, et al.
Publicado: (2015)

Overactive bladder
por: Wallace, Karen M., et al.
Publicado: (2015)

Is overactive bladder in the female surgically curable by ligament repair?
por: Liedl, Bernhard, et al.
Publicado: (2017)

Postmenopausal overactive bladder
por: Tomaszewski, Jacek
Publicado: (2014)

Neuromodulation – a therapeutic option for refractory overactive bladder. A recent literature review
por: Szymański, Jacek K., et al.
Publicado: (2019)

Do we need more patient‐friendly treatment options for overactive bladder (OAB)?
por: Gerig, Nel, et al.
Publicado: (2021)

Urodynamic Detrusor Overactivity in Patients with Overactive Bladder Symptoms
por: Al-Ghazo, Mohammed A., et al.
Publicado: (2011)

A watershed paper for surgical cure of overactive bladder and nocturia
por: Petros, Peter
Publicado: (2021)

The surgical effect on overactive bladder symptoms in women with pelvic organ prolapse
por: Wu, Ling-Ying, et al.
Publicado: (2021)

Pharmacologic management of overactive bladder
por: Lam, Sum, et al.
Publicado: (2007)

Medical management of overactive bladder
por: Ubee, Sarvpreet S., et al.
Publicado: (2010)

Overactive bladder in the vulnerable elderly
por: Wolff, Gillian F, et al.
Publicado: (2014)

Urinary biomarkers of overactive bladder
por: Tian, Xiao-Jun, et al.
Publicado: (2019)

Review of the epidemiology of overactive bladder
por: Eapen, Renu S, et al.
Publicado: (2016)

Impact of depression on overactive bladder
por: Kawahara, Takashi, et al.
Publicado: (2020)

Current pharmacotherapy of overactive bladder
por: Kreydin, Evgenyi I., et al.
Publicado: (2021)

Update on the management of overactive bladder
por: Fontaine, Christina, et al.
Publicado: (2021)

Mediterranean Diet and Overactive Bladder
por: Bozkurt, Yunus Erol, et al.
Publicado: (2022)

Telemedicine in Overactive Bladder Syndrome
por: Jericevic, Dora, et al.
Publicado: (2023)

Updates of Overactive Bladder in Pediatrics
por: Shim, Jisung, et al.
Publicado: (2023)

Urodynamic and Bladder Diary Factors Predict Overactive Bladder-wet in Women: A Comparison With Overactive Bladder-dry
por: Hsiao, Sheng-Mou, et al.
Publicado: (2019)

Pharmacokinetics of solifenacin in pediatric populations with overactive bladder or neurogenic detrusor overactivity
por: Tannenbaum, Stacey, et al.
Publicado: (2020)

Impact of a direct-to-consumer information campaign on prescription patterns for overactive bladder
por: Zaitsu, Masayoshi, et al.
Publicado: (2018)

Overactive bladder with urodynamic study-induced bladder pain: An overactive bladder subtype with symptoms similar to those of interstitial cystitis/painful bladder syndrome
por: Mu, Hsueh-Yu, et al.
Publicado: (2023)

Coexisting overactive–underactive bladder and detrusor overactivity–underactivity in pelvic organ prolapse
por: Frigerio, Matteo, et al.
Publicado: (2022)

Recent advances in management of bladder overactivity
por: Smith, Ariana L, et al.
Publicado: (2010)

Transdermal oxybutynin in the treatment of overactive bladder
por: Davila, G Willy
Publicado: (2006)

Overactive Bladder: Pathophysiology, Diagnostics, and Therapies
por: Heesakkers, John P. F. A., et al.
Publicado: (2011)

OnabotulinumtoxinA for the treatment of overactive bladder
por: Cox, Lindsey, et al.
Publicado: (2014)

Role of fesoterodine in the treatment of overactive bladder
por: Mansfield, Kylie J
Publicado: (2009)

Overactive bladder induces transient hypertension
por: Torimoto, Kazumasa, et al.
Publicado: (2018)

Individualizing medical treatment of overactive bladder
por: Kuo, Hann-Chorng
Publicado: (2018)

Impact of overactive bladder on retrograde ejaculation
por: Salvarci, Ahmet, et al.
Publicado: (2018)

Efficacy of tolterodine in children with overactive bladder
por: Koç, Başak, et al.
Publicado: (2020)

Vaginal laser for overactive bladder syndrome
por: Charalampous, Ioannis, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7qee0pmma5elaefeqhe206spl4